Accès ouvert
2026
article
OpenAlex
Mona Alotaibi, Lloyd D. Harvey, William C. Nichols, Michael W. Pauciulo et autres
Pulmonary arterial hypertension (PAH) is a rare and fatal vascular disease with heterogeneous clinical manifestations. To date, molecular determinants underlying the development of PAH and related outcomes remain poorly understood. Herein, we identify pulmonary primary oxysterol and bile acid synthesis (PPOBAS) as …
us, fi, sa, fr
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Chen-Shan Chen Woodcock, Giovanni Maroli, Hyunbum Kim, Yi‐Yin Tai et autres
BACKGROUND: Early apoptosis of pulmonary artery endothelial cells (PAECs) is a driver of vascular remodeling and pulmonary hypertension (PH), but its regulation is poorly defined. Adenosine deaminase acting on RNA 1 (ADAR1, gene name ADAR ) is an RNA editing enzyme that …
us, de, fr
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Yunhye Kim, Giovanni Maroli, Chen-Shan Chen Woodcock, Hyunbum Kim et autres
BACKGROUND: ADAR1 (adenosine deaminase acting on RNA 1) catalyzes the conversion of adenosine to inosine in double stranded RNAs (dsRNAs), which is critical to prevent autoinflammatory responses mediated by activation of the type I IFN (interferon) signaling. We define the role of …
us, de, gb, fr
(code pays fourni par la source)
2025
erratum
OpenAlex
Qiujun Yu, Yi-Yin Tai, Ying Tang, Jingsi Zhao et autres
Accès ouvert
2025
article
OpenAlex
Lloyd D. Harvey, Mona Alotaibi, Yi‐Yin Tai, Ying Tang et autres
Vascular inflammation regulates endothelial pathophenotypes, particularly in pulmonary arterial hypertension (PAH). Dysregulated lysosomal activity and cholesterol metabolism activate pathogenic inflammation, but their relevance to PAH is unclear. Nuclear receptor coactivator 7 ( NCOA7 ) deficiency in endothelium produced an oxysterol and bile …
us, fr
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Stéphanie Torrino, William M. Oldham, Andrés R. Tejedor, Ignacio Sanchez‐Burgos et autres
fr, us, es, gb
(code pays fourni par la source)
2024
article
OpenAlex
Florent Murcy, Coraline Borowczyk, Samuel Gourion‐Arsiquaud, Stéphanie Torrino et autres
fr, us, fi
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Nesrine Rachedi, Ying Tang, Yi-Yin Tai, Jingsi Zhao et autres
fr, us
(code pays fourni par la source)
2024
conference-abstract
OpenAlex
Rashmi Rao, Hee-Jung Kim, Shan Jiang, Yi‐Yin Tai et autres
us, fr
(code pays fourni par la source)
Accès ouvert
2024
preprint
OpenAlex
Lloyd D. Harvey, Mona Alotaibi, Hee-Jung Janice Kim, Yi‐Yin Tai et autres
Vascular inflammation critically regulates endothelial cell (EC) pathophenotypes, particularly in pulmonary arterial hypertension (PAH). Dysregulation of lysosomal activity and cholesterol metabolism have known inflammatory roles in disease, but their relevance to PAH is unclear. In human pulmonary arterial ECs and in PAH, …
us, fr
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Yi‐Yin Tai, Qiujun Yu, Ying Margie Tang, Wei Sun et autres
Hypoxic reprogramming of vasculature relies on genetic, epigenetic, and metabolic circuitry, but the control points are unknown. In pulmonary arterial hypertension (PAH), a disease driven by hypoxia inducible factor (HIF)–dependent vascular dysfunction, HIF-2α promoted expression of neighboring genes, long noncoding RNA (lncRNA) …
us, fr, jp, gb
(code pays fourni par la source)
2023
conference-abstract
OpenAlex
Rashmi J. Rao, Heejung Kim, Siyi Jiang, Yi‐Yin Tai et autres
Introduction: Pulmonary hypertension (PH) is a fatal disease without a cure, in which endothelial dysfunction drives pathologic remodeling of the pulmonary vasculature. Individuals with Smith-Lemli-Opitz syndrome (SLOS) develop PH, but the underlying mechanisms remain undefined. SLOS is an autosomal recessive disorder of …
us, fr
(code pays fourni par la source)